Taken together, these results prove that Sema3A not only negatively affects OXPHOS but also negatively affects the cell’s ability to produce energy if the need arises, and that it may also inhibit glycolysis in activated T cells taken from RA patients. The gene discussed is SEMA3A; the disease is rheumatoid arthritis.